摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5-[2-(7-cyclohexyl-6-dimethylcarbamoyl-7H-pyrrolo[2,3-d]pyrimidin-2-ylamino)pyrimidine-5-carbonyl]-2,5-diazabicyclo[2.2.1]heptane-2-carboxylic acid tert-butyl ester | 1331847-04-1

中文名称
——
中文别名
——
英文名称
5-[2-(7-cyclohexyl-6-dimethylcarbamoyl-7H-pyrrolo[2,3-d]pyrimidin-2-ylamino)pyrimidine-5-carbonyl]-2,5-diazabicyclo[2.2.1]heptane-2-carboxylic acid tert-butyl ester
英文别名
Tert-butyl 5-[6-[[7-cyclohexyl-6-(dimethylcarbamoyl)pyrrolo[2,3-d]pyrimidin-2-yl]amino]pyridine-3-carbonyl]-2,5-diazabicyclo[2.2.1]heptane-2-carboxylate
5-[2-(7-cyclohexyl-6-dimethylcarbamoyl-7H-pyrrolo[2,3-d]pyrimidin-2-ylamino)pyrimidine-5-carbonyl]-2,5-diazabicyclo[2.2.1]heptane-2-carboxylic acid tert-butyl ester化学式
CAS
1331847-04-1
化学式
C31H40N8O4
mdl
——
分子量
588.71
InChiKey
JOHXLCAXSZCMCL-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.6
  • 重原子数:
    43
  • 可旋转键数:
    7
  • 环数:
    6.0
  • sp3杂化的碳原子比例:
    0.55
  • 拓扑面积:
    126
  • 氢给体数:
    1
  • 氢受体数:
    8

文献信息

  • PYRROLOPYRIMIDINE COMPOUNDS AS INHIBITORS OF CDK4/6
    申请人:Brain Christopher Thomas
    公开号:US20130150342A1
    公开(公告)日:2013-06-13
    The invention is directed to novel pyrrolopyrimidine compounds of formula (I) wherein R 1 , R 2Y , R 4 , R 8 -R 11 , A and L are defined herein and to salts, including pharmaceutically acceptable salts thereof. The compounds of the present invention are CDK4/6 inhibitors and could be useful in the treatment of diseases and disorders mediated by CDK4/6, such as cancer, including mantle cell lymphoma, liposarcoma, non small cell lung cancer, melanoma, squamous cell esophageal cancer and breast cancer. The invention is further directed to pharmaceutical compositions comprising a compound of the invention. The invention is still further directed to methods of inhibiting CDK4/6 activity and to the treatment of disorders associated therewith using a compound of the invention or a pharmaceutical composition comprising a compound of the invention.
    本发明涉及公式(I)的新型吡咯嘧啶化合物,其中R1,R2Y,R4,R8-R11,A和L在此处定义,并且包括其盐,包括医药上可接受的盐。本发明的化合物是CDK4/6抑制剂,可用于治疗由CDK4/6介导的疾病和障碍,如癌症,包括曼托细胞淋巴瘤,脂肪肉瘤,非小细胞肺癌,黑色素瘤,鳞状细胞食管癌和乳腺癌。本发明还涉及包含本发明化合物的制药组合物。本发明还涉及使用本发明化合物或包含本发明化合物的制药组合物来抑制CDK4/6活性和治疗与之相关的障碍的方法。
  • US8957074B2
    申请人:——
    公开号:US8957074B2
    公开(公告)日:2015-02-17
  • US9309252B2
    申请人:——
    公开号:US9309252B2
    公开(公告)日:2016-04-12
查看更多